For instance, in pancreatic ductal adenocarcinoma, PDAC, CAF-secreted CXCL12 (SDF-1), has been reported to increase SATB1 expression in tumor cells and to contribute to gemcitabine resistance [77]. Here, CXCL12 is linked to neoplasm.